Back to ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

PBYIPBYI
Showing 7 of 15 quarters

Position history for ARROWSTREET CAPITAL, LIMITED PARTNERSHIPARROWSTREET CAPITAL, LIMITED PARTNERSHIP's holdings in PUMA BIOTECHNOLOGY INC

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds 532,450 shares of PBYI (PUMA BIOTECHNOLOGY INC), worth $4.3M as of 2026-Q2. The position was decreased (-1.1% shares). PBYI represents 0.0% of ARROWSTREET CAPITAL, LIMITED PARTNERSHIP's portfolio.

Current Value

$4.3M

Current Shares

532,450

Total Value Change

+$4.3M

Total Shares Change

+532,450

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
532,450
-1.1%
$4.3M0.0%$8.11
0
2026-Q1
Decreased
538,155
-1.8%
$3.4M0.0%$6.21
0
2025-Q4
Increased
547,853
+17.9%
$3.3M0.0%$6.01
31
2025-Q3
Increased
464,734
+2.9%
$2.5M0.0%$5.05
27
2025-Q2
Increased
451,633
+25.9%
$1.5M0.0%$3.33
32
2025-Q1
New
358,621
-
$1.1M0.0%$3.14
35
2024-Q3
Exited
0
-100.0%
$00.0%$2.58
0

Other major holders of PBYI: BLACKROCK ADVISORS LLC, FEDERATED HERMES, INC., BNP PARIBAS FINANCIAL MARKETS, FRED ALGER MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used